Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PASHTOON KASI

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1215167648
CMS profile
1251566
Location
IRVINE, CA

General Payments · PY2018–2024

$83,909.49

  • Reported across 66 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$18,019.59

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $17,583.00 7
Food and Beverage $436.59 9

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,916.14 4
PY2019 $1,417.31 6
PY2020 $900.00 1
PY2021 $29,801.99 11
PY2022 $22,244.80 18
PY2023 $9,609.66 10
PY2024 $18,019.59 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $79.61 11/04/2024 Food and Beverage Undisputed 01/23/2026 1115790016 CMS
Astellas Pharma US Inc $16.46 09/25/2024 Food and Beverage Undisputed 01/23/2026 1139396647 CMS
AstraZeneca Pharmaceuticals LP $24.26 04/02/2024 Food and Beverage Undisputed 01/23/2026 1105284149 CMS
AstraZeneca Pharmaceuticals LP $24.62 05/29/2024 Food and Beverage Undisputed 01/23/2026 1105819405 CMS
Bayer Healthcare Pharmaceuticals Inc. $1,750.00 01/17/2024 Consulting Fee Undisputed 01/23/2026 1086110020 CMS
BeiGene USA, Inc. $107.33 06/10/2024 Food and Beverage Undisputed 01/23/2026 1120853411 CMS
BeiGene USA, Inc. $2,250.00 06/10/2024 Consulting Fee Undisputed 01/23/2026 1120853413 CMS
Ipsen Biopharmaceuticals, Inc $23.59 06/12/2024 Food and Beverage Undisputed 01/23/2026 1091966794 CMS
Menarini Silicon Biosystems, Inc. $102.44 12/06/2024 Food and Beverage Undisputed 01/23/2026 1100676318 CMS
Novartis Pharmaceuticals Corporation $31.25 11/18/2024 Food and Beverage Undisputed 01/23/2026 1087151306 CMS
Regeneron Pharmaceuticals, Inc. $881.00 08/14/2024 Consulting Fee Undisputed 01/23/2026 1114400785 CMS
Regeneron Pharmaceuticals, Inc. $5,286.00 08/14/2024 Consulting Fee Undisputed 01/23/2026 1114400787 CMS
Regeneron Pharmaceuticals, Inc. $927.00 08/14/2024 Consulting Fee Undisputed 01/23/2026 1114400789 CMS
Regeneron Pharmaceuticals, Inc. $4,635.00 08/14/2024 Consulting Fee Undisputed 01/23/2026 1114400791 CMS
Regeneron Pharmaceuticals, Inc. $1,854.00 08/14/2024 Consulting Fee Undisputed 01/23/2026 1114400793 CMS
Tempus AI, Inc $27.03 10/22/2024 Food and Beverage Undisputed 01/23/2026 1150167366 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.